^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    englumafusp alfa (RG6076)

    i
    Associations
    News
    Trials
    Company:
    Roche
    Drug class:
    CD19 inhibitor, CD137 agonist
    Related drugs:
    Associations
    News
    Trials